NLTX Neoleukin Therapeutics Inc

5,130

$4.02

$0.07

(1.77%)

Today

Watchers	5,130
52-Wk Low	$1.88
52-Wk High	$4.70

Market Cap	$176.97M
Volume (M)	21,699.00
52-Wk High	$4.70
52-Wk Low	$1.88

Fundamentals

Neoleukin Therapeutics Announces 1-for-5 Reverse Stock SplitGlobe Newswire • 11 days ago

SEATTLE, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., Neoleukin or the Company (NASDAQ:NLTX), a biopharmaceutical company that has designed de novo protein therapeutics...

Share to Feed

Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Shares Acquired by US Bancorp DEZolmax • 29 days ago

US Bancorp DE boosted its position in shares of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX Free Report) by 111.2% during the first quarter, according to the company in its most recent Form...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCCI, CCF, SCU, NLTXPR Newswire • about 1 month ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCCI, CCF, SCU, NLTX SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCCI, CCF, SCU, NLTX PR Newswire NEW YORK, Aug. 22, 2023 NEW YORK, Aug. 22, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the...

Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Director Acquires $1,189,944.00 in StockZolmax • about 1 month ago

Neoleukin Therapeutics, Inc. (NASDAQ:NLTX Get Free Report) Director Bros. Advisors Lp Baker acquired 1,888,800 shares of the stock in a transaction that occurred on Tuesday, August 15th. The shares were bought at an average price of $0.63 per share, with a total value of $1,189,944.00. Following the...

Insider Buying: Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Director Buys 166,942 Shares of StockTicker Report • about 1 month ago

Neoleukin Therapeutics, Inc. (NASDAQ:NLTX Get Free Report) Director Bros. Advisors Lp Baker purchased 166,942 shares of Neoleukin Therapeutics stock in a transaction that occurred on...

BAKER BROS. ADVISORS LP Reduces Stake in Neoleukin Therapeutics IncGuruFocus • about 2 months ago

Related Stocks: NLTX, ACAD, BGNE, INCY, MDGL, SGEN...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NLTX, SCU, AMNBGlobe Newswire • about 2 months ago

NEW YORK, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

SHAREHOLDER ALERT: Morris Kandinov Investigating HAFC, CVNA, PEGA, and NLTX; Shareholders are Encouraged to Contact the FirmGlobe Newswire • about 2 months ago

SAN DIEGO, Aug. 16, 2023 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Hanmi Financial Corporation, Carvana Co., Pegasystems Inc., and Neoleukin Therapeutics, Inc. If you are a current owner of shares of any of these ...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRDS, CCF, NLTX, SCUPR Newswire • about 2 months ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRDS, CCF, NLTX, SCU SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRDS, CCF, NLTX, SCU PR Newswire NEW YORK, Aug. 15, 2023 NEW YORK, Aug. 15, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the...

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - SCU, DEN, NLTX, BGGlobe Newswire • about 2 months ago

NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the M&A Class Action Firm), a national securities firm ratedTop 50in the 2018-2021 ISS Securities Class Action Services Report and headquartered at theEmpire...